pharma-company /Medicinal products /Active ingredients

Rx · PZN 15246391

POTELIGEO 4 mg/ml 20mg concentrate for preparation of an infusion-solution vial

German trade namePOTELIGEO 4 mg-ml 20mg Konzentrat zur Herstellung Infusionslösung Durchstechflasche

Active ingredientMogamulizumab

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €1,067

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for POTELIGEO 4 mg/ml 20mg concentrate for preparation of an infusion-solution vial.

Review purchasing terms

POTELIGEO 4 mg/ml 20mg concentrate for preparation of an infusion-solution vial contains the active ingredient Mogamulizumab. One pack size is recorded (PZN 15246391). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability.


POTELIGEO 4 mg/ml 20mg concentrate for preparation of an infusion-solution vial was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.